Next Article in Journal
Synthesis of a Cholesteryl-HEG Phosphoramidite Derivative and Its Application to Lipid-conjugates of the Anti-HIV 5'TGGGAG3' Hotoda’s Sequence
Previous Article in Journal
Two New Cholic Acid Derivatives from the Marine Ascidian-Associated Bacterium Hasllibacter halocynthiae
Article Menu

Export Article

Open AccessArticle
Molecules 2012, 17(10), 12365-12377; doi:10.3390/molecules171012365

Phenylmethimazole Blocks dsRNA-Induced IRF3 Nuclear Translocation and Homodimerization

1
Department of Specialty Medicine, Ohio University, Athens, OH 45701, USA
2
Interthyr Corporation, Athens, OH 45701, USA
3
Biomedical Engineering Program, Ohio University Russ College of Engineering & Technology, Ohio University, Athens, OH 45701, USA
4
Department of Chemical and Biomolecular Engineering, Ohio University Russ College of Engineering & Technology, Ohio University, Athens, OH 45701, USA
5
Diabetes Institute, Ohio University College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA
6
Department of Biological Sciences, Ohio University College of Arts & Sciences, Ohio University, Athens, OH 45701, USA
7
Molecular & Cellular Biology Program, Ohio University College of Arts & Sciences, Ohio University, Athens, OH 45701, USA
*
Author to whom correspondence should be addressed.
Received: 5 October 2012 / Revised: 16 October 2012 / Accepted: 19 October 2012 / Published: 22 October 2012
View Full-Text   |   Download PDF [856 KB, 18 June 2014; original version 18 June 2014]   |  

Abstract

Previous studies revealed that phenylmethimazole (C10) inhibits IRF3 signaling, preventing dsRNA-induction of type 1 interferon gene expression, production, and downstream signaling. In the present study, we investigated the molecular basis for C10 inhibition of dsRNA-stimulated IRF3 signaling. IRF-3 Trans-AM assays were used to measure C10 effects on dsRNA induction of IRF3 DNA binding. Green fluorescent protein-labeled IRF3 was used to measure C10 effects on dsRNA-induced IRF3 nuclear translocation. Native PAGE, SDS PAGE, and western blotting were used to identify effects of C10 on IRF3 homodimer formation and phosphorylation, respectively. There was a significant impairment of dsRNA-induced IRF3 DNA binding activity in human embryonic kidney and pancreatic cancer cells with C10 treatment. C10 also blocked dsRNA-induced IRF3 nuclear translocation and homodimer formation without blocking serine 396 phosphorylation of IRF3. Together, these results indicate that C10 interferes with IRF3 signaling by blocking dsRNA-induced IRF3 homodimer formation, a prerequisite for nuclear translocation and DNA binding activities. View Full-Text
Keywords: phenylmethimazole (C10); IRF3 phenylmethimazole (C10); IRF3
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Courreges, M.C.; Kantake, N.; Goetz, D.J.; Schwartz, F.L.; McCall, K.D. Phenylmethimazole Blocks dsRNA-Induced IRF3 Nuclear Translocation and Homodimerization. Molecules 2012, 17, 12365-12377.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top